COVID-19 vaccine strategies must focus on severe disease and global equity
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
McIntyre, Peter BAggarwal, Rakesh
Jani, Ilesh
Jawad, Jaleela
Kochhar, Sonali
MacDonald, Noni
Madhi, Shabir A
Mohsni, Ezzeddine
Mulholland, Kim
Neuzil, Kathleen M
Nohynek, Hanna
Olayinka, Folake
Pitisuttithum, Punnee
Pollard, Andrew J
Cravioto, Alejandro
Date
2021-12Journal
Lancet (London, England)Publisher
ElsevierType
Article
Metadata
Show full item recordSee at
https://doi.org/10.1016/S0140-6736(21)02835-Xhttp://www.ncbi.nlm.nih.gov/pmc/articles/pmc8676417/
Keyword
COVID-19Identifier to cite or link to this item
http://hdl.handle.net/10713/17640ae974a485f413a2113503eed53cd6c53
10.1016/s0140-6736(21)02835-x
Scopus Count
Related articles
- Five priorities for universal COVID-19 vaccination.
- Authors: Abecassis A
- Issue date: 2021 Jul 24
- Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
- Authors: Wang W, Wu Q, Yang J, Dong K, Chen X, Bai X, Chen X, Chen Z, Viboud C, Ajelli M, Yu H
- Issue date: 2020 Dec 15
- COVID-19: vaccination problems.
- Authors: Brüssow H
- Issue date: 2021 Jun
- The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
- Authors: Rid A, Lipsitch M, Miller FG
- Issue date: 2021 Jan 19
- Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.
- Authors: Botton J, Semenzato L, Jabagi MJ, Baricault B, Weill A, Dray-Spira R, Zureik M
- Issue date: 2022 Mar 1